The federal government says it’s spending $214 million to support “made in Canada” coronavirus vaccine research.
Prime Minister Justin Trudeau announced Friday that $173 million would go to Quebec-based Medicago, while Vancouver’s Precision NanoSystems would receive $18.2 million for development and testing.
“This is about securing potential vaccines for Canadians while supporting good jobs in research,” he told reporters at a press conference in Ottawa.
The deal with Medicago includes up to 76 million doses of its vaccine candidate, as well as funds to set up a production facility in Quebec City.
A further $23 million will go toward the National Research Council of Canada Industrial Research Assistance Program.
Trudeau’s announcement came after Canada posted a record increase in new COVID-19 cases on Thursday, with nearly 2,800 people newly diagnosed with the illness.
“We have to get these numbers down,” Trudeau said. “This is serious and everybody must do their part.”
Coronavirus: Trudeau says Canada has surpassed 200,000 COVID-19 cases
© 2020 Global News, a division of Corus Entertainment Inc.